Minyanville's daily roundup of some of the best financial commentary on emerging markets from around the Web. Bloomberg: Business Week Link: Indian Drug Regulator Accused of Corruption and Collusion India’s top drug regulatory agency violated laws and colluded with pharmaceutical companies to approve medicines without clinical trials a parliamentary panel said in a report. The Central Drugs Standard Control Organization which oversees clinical trials and India’s 10 000 drugmakers approved medicines from companies including Novartis AG (NOVN.VX)  GlaxoSmithKline Plc (GSK) and Mumbai-based Cipla Ltd. (CIPLA.NS) without clinical trials required to be done in the country the standing committee on health and family welfare said in ...